ATE404183T1 - AGENT CONTAINING ERGOLIN FOR TRANSDERMAL APPLICATION - Google Patents

AGENT CONTAINING ERGOLIN FOR TRANSDERMAL APPLICATION

Info

Publication number
ATE404183T1
ATE404183T1 AT04735452T AT04735452T ATE404183T1 AT E404183 T1 ATE404183 T1 AT E404183T1 AT 04735452 T AT04735452 T AT 04735452T AT 04735452 T AT04735452 T AT 04735452T AT E404183 T1 ATE404183 T1 AT E404183T1
Authority
AT
Austria
Prior art keywords
ergolin
agent containing
transdermal application
tert
stabilized
Prior art date
Application number
AT04735452T
Other languages
German (de)
Inventor
Reinhard Horowski
Johannes Tack
Katalin Tisa Bostedt
Dirk Schenk
Original Assignee
Axxonis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axxonis Pharma Ag filed Critical Axxonis Pharma Ag
Application granted granted Critical
Publication of ATE404183T1 publication Critical patent/ATE404183T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a transdermal therapeutic system containing ergolin compounds, preferably lisuride, in which the ergolin compound is stabilized. The oxidation-sensitive ergolin compound is stabilized by a combination of at least one liposoluble, free radical-scavenging antioxidant, preferably di-tert.-butyl methyl phenol, di-tert.-butyl metoxy phenol, tocopherol or ubiquinone and a basic polymer.
AT04735452T 2003-09-03 2004-05-30 AGENT CONTAINING ERGOLIN FOR TRANSDERMAL APPLICATION ATE404183T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10341317A DE10341317B4 (en) 2003-09-03 2003-09-03 Transdermal therapeutic system (TTS) for administration of ergoline compounds except pergolide

Publications (1)

Publication Number Publication Date
ATE404183T1 true ATE404183T1 (en) 2008-08-15

Family

ID=34223453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04735452T ATE404183T1 (en) 2003-09-03 2004-05-30 AGENT CONTAINING ERGOLIN FOR TRANSDERMAL APPLICATION

Country Status (15)

Country Link
US (1) US20070134309A1 (en)
EP (1) EP1660054B1 (en)
JP (1) JP2007504257A (en)
AT (1) ATE404183T1 (en)
AU (1) AU2004271679B2 (en)
CA (1) CA2504885A1 (en)
DE (2) DE10341317B4 (en)
DK (1) DK1660054T3 (en)
ES (1) ES2311825T3 (en)
HK (1) HK1086742A1 (en)
NZ (1) NZ546178A (en)
PL (1) PL1660054T3 (en)
PT (1) PT1660054E (en)
SI (1) SI1660054T1 (en)
WO (1) WO2005025546A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
JP5037831B2 (en) * 2006-02-15 2012-10-03 久光製薬株式会社 External patch for improving cohesion and sustained release
DE102006013307B3 (en) * 2006-03-21 2007-10-04 Ergonex Pharma Gmbh Terguride / proterguride for the treatment of chronic pain
DE102006048130A1 (en) * 2006-10-06 2008-04-10 Axxonis Pharma Ag Transdermal therapeutic system with biphasic release profile

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5674875A (en) * 1993-05-04 1997-10-07 Eli Lilly And Company Method of blocking human 5-hydroxytryptamine-2 receptors
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (en) * 1996-07-02 1998-01-08 Hexal Ag Plaster for transdermal application of pergolide
US6623752B1 (en) * 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
GB9711043D0 (en) * 1997-05-29 1997-07-23 Ciba Geigy Ag Organic compounds
DE19821788C1 (en) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermal therapeutic system (TTS) containing pergolide
DE10054713C2 (en) * 1999-11-29 2002-07-18 Lohmann Therapie Syst Lts Transdermal therapeutic systems with improved stability and a method for their production
DE10043321B4 (en) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Use of a transdermal therapeutic system for the treatment of Parkinson's disease, for the treatment and prevention of premenstrual syndrome and for lactation inhibition
CA2443128A1 (en) * 2001-03-30 2002-10-10 Debra A. Martin Transdermal delivery of pergolide
US20040120995A1 (en) * 2002-04-01 2004-06-24 Martin Debra A Transdermal delivery of pergolide

Also Published As

Publication number Publication date
JP2007504257A (en) 2007-03-01
SI1660054T1 (en) 2008-12-31
EP1660054B1 (en) 2008-08-13
ES2311825T3 (en) 2009-02-16
PT1660054E (en) 2008-10-08
WO2005025546A1 (en) 2005-03-24
EP1660054A1 (en) 2006-05-31
HK1086742A1 (en) 2006-09-29
NZ546178A (en) 2008-12-24
AU2004271679B2 (en) 2007-09-20
US20070134309A1 (en) 2007-06-14
CA2504885A1 (en) 2005-03-24
DK1660054T3 (en) 2008-11-17
AU2004271679A1 (en) 2005-03-24
DE502004007855D1 (en) 2008-09-25
DE10341317A1 (en) 2005-03-31
DE10341317B4 (en) 2008-10-23
PL1660054T3 (en) 2009-01-30

Similar Documents

Publication Publication Date Title
CY1105387T1 (en) SUBSTITUTED 2-DIALKYLAMINOALKYLBIFINTHIUM DERIVATIVES
SE0301700D0 (en) Novel compounds
EA201000089A1 (en) APPLICATION OF HOMO- AND COPOLYMERS TO STABILIZE THE COMPOSITIONS OF ACTIVE INGREDIENTS
DK1615646T4 (en) PHARMACEUTICAL FORMULATIONS CONTAINING METHYLNALTREXONE
ATE448777T1 (en) AGENT FOR TRANSDERMAL ADMINISTRATION OF NICOTINE
DE60205749D1 (en) ORAL DRUG COMPOSITIONS TO BE APPLIED WITH A TAXED ACTIVE SUBSTANCE
EA201170772A1 (en) ORGANIC COMPOUNDS
SG145715A1 (en) Mitoquinone derivatives used as mitochondrially targeted antioxidants
BRPI0417578A (en) endoparasiticidal compositions for topical application
PA8624601A1 (en) MACROLIDES AND METHODS TO PRODUCE THE SAME
BRPI0515721A (en) use of a src kinase inhibitor and a bcr-abl inhibitor, pharmaceutical composition and combination
ES2328496T3 (en) 1,4,8-TRIAZA-ESPIRO (4,5) DECAN-2-ONA SUBSTITUTED COMPOUNDS.
CL2007002106A1 (en) LIQUID MONOPHASIC COMPOSITION THAT INCLUDES 3 ANTIOXIDANTS, 1st, SYNTHETIC PHENOLIC COMPOUND THAT IS NOT DERIVED FROM QUINOOLINE, 2nd, PHENOLIC, ASCORBIC ACIDES, TOCOPHEROLS, LECITINE, BIOFLAVONOID OR THERPENOLINE, OR 3;
ATE401863T1 (en) NEW VISCOELASTIC COMPOSITION COMPRISING ALGINATE AND VITAMIN E TPGS OR TPGSA
BRPI0413742A (en) mitoquinone derivatives used as mitochondrially targeted antioxidants
UY27852A1 (en) DIFENILAZATIDINONAS CATIONICAMENTE REPLACED, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
HK1086742A1 (en) Agent containing ergolin for transdermal application
DE602007012471D1 (en) FILLED PLASTIC COMPOSITION
SE0302546D0 (en) New compounds
ATE498600T1 (en) INDENE DERIVATIVES AS PHARMACEUTICALS
PA8605101A1 (en) 4- (AMINOMETIL) -PIPERIDIN BENZAMIDAS AS AN 5GT4 ANTAGONIST
TW200503737A (en) Water soluble wortmannin derivatives
DE602004026410D1 (en) SYNDICOTACTIC PROPYLENE POLYMER CONTAINING COMPOSITION
EA200600590A1 (en) PHARMACEUTICAL COMPOSITIONS OF MODAFINIL WITH MODIFIED DELIVERY
DE602004019083D1 (en) OXYGEN BARRIER FORMULATIONS

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee